NovaBay Pharma's total assets for Q2 2025 were $6.91M, a decrease of -29.99% from the previous quarter. NBY total liabilities were $2.67M for the fiscal quarter, a -28.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.